Lartan 50 Tablet contains Losartan 50 mg, an angiotensin II receptor antagonist used primarily for the management of hypertension. By selectively blocking the binding of angiotensin II to the AT1 receptor, Losartan promotes vasodilation, thereby reducing peripheral vascular resistance and lowering blood pressure. This mechanism helps prevent complications associated with hypertension, including stroke, myocardial infarction, and renal impairment. Lartan 50 is also indicated for the treatment of diabetic nephropathy in patients with type 2 diabetes and proteinuria, as it helps to slow the progression of kidney damage. The tablet is typically administered once daily, with or without food, and dosage adjustments may be necessary based on clinical response and patient tolerance. Common adverse effects include dizziness, upper respiratory infections, and fatigue, though the medication is generally well tolerated. Caution is advised in patients with renal or hepatic impairment, and it is contraindicated during pregnancy due to potential teratogenic effects. Regular monitoring of blood pressure, renal function, and electrolytes is recommended during therapy. Lartan 50 Tablet should be used under medical supervision to ensure optimal therapeutic outcomes and minimize risks.